[1]SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics[J].CA Cancer J Clin,2016,66(1):7-30.
[2]MACDONALD JS,SMALLEY SR,BENEDETTI J,et al.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction[J].N Engl J Med,2001,345:725-730.
[3]KUTTY RK,KUTTY G,SAMUEL W,et al.Molecular characterization and developmental expression of NORPEG,a novel gene induced by retinoic acid[J].J Biol Chem,2001,276(4):2831-2840.
[4]HE XY,ZHAO J,LIU CY,et al.High expression of retinoic acid induced 14 (RAI14) in gastric cancer and its prognostic value[J].Med Sci Monit,2018,24:2244-2251.
[5]PAEZ AV,PALLAVICINI C,SCHUSTER F,et al.Heme oxygenase-1 in the forefront of a multi-molecular network that governs cell-cell contacts and filopodia-induced zippering in prostate cancer[J].Cell Death Dis,2016,7(12):e2570.
[6]HAWKINS SM,LOOMANS HA,WAN YW,et al.Expression and functional pathway analysis of nuclear receptor NR2F2 in ovarian cancer[J].J Clin Endocrinol Metab,2013,98(7):1152-1162.
[7]YUAN C,HU H,KUANG M,et al.Super enhancer associated RAI14 is a new potential biomarker in lung adenocarcinoma[J].Oncotarget,2017,8(62):105251-105261.
[8]VENDROV AE,EDIATED MADAMANCHI NR,HAKIM ZS,et al.Thrombin and NAD(P)H oxiaase-meaiated regulation of CD44 and BMP4-Id pathway in VSMC,restenosis,and atherosclerosis[J].Circulation Research,2006,98(10):1254-1263.
[9]IYANAGI T.Molecular mechanism of metabolic NAD(P)H-dependent electron-transfer systems:The role of redox cofactors[J].Biochim Biophys Acta Bioenerg,2019,1860(3):233-258.
[10]REIS R,SALVI F,WILLIAMS I,et al.Kinetic investigation of a presumed nitronate monooxygenase from pseudomonas aeruginosa PAO1 establishes a new class of NAD(P)H:Quinone reductases[J].Biochemistry,2019,58(22):2594-2607.
[11]SHEN X,ZHANG J,ZHANG X,et al.Retinoic acid-induced protein 14 (RAI14) promotes mTOR-mediated inflammation under inflammatory stress and chemical hypoxia in a U87 glioblastoma cell line[J].Cell Mol Neurobiol,2019,39(2):241-254.
[12]HANAHAN D,WEINBERG RA.Hallmarks of cancer:The next generation[J].Cell,2011,144(5):646-674.
[13]CARMELIET P,JAIN RK.Angiogenesis in cancer and other diseases[J].Nature,2000,407(6801):249-257.
[14]NIENHSER H,SCHMIDT T.Angiogenesis and anti-angiogenic therapy in gastric cancer[J].Int J Mol Sci,2017,19(1):e43.
[15]PINTO MP,OWEN GI,RATAMAL I,et al.Angiogenesis inhibitors in early development for gastric cancer[J].Expert Opin Investig Drugs,2017,26(9):1007-1017.
[16]JIN Z,YOON HH.Antiangiogenic therapy in gastroesophageal cancer[J].Hematol Oncol Clin North Am,2017,31(3):499-510.
[17]ROVIELLO G,RAVELLI A,FIASCHI AI,et al.Apatinib for the treatment of gastric cancer[J].Expert Rev Gastroenterol Hepatol,2016,10(8):887-892.
[18]BROWER V.Apatinib in treatment of refractory gastric cancer[J].Lancet Oncol,2016,17(4):e137.
[19]LI J,QIN S,XU J,et al.Randomized,double-blind,placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal munction[J].J Clin Oncol,2016,34(13):1448-1454.
[20]LI J,QIN S,XU J,et al.Apatinib for chemotherapy-refractory advanced metastatic gastric cancer:Results from a randomized,placebo-controlled,parallel-arm,phase II trial[J].J Clin Oncol,2013,31(26):3219-3225.
[21]ZHOU J,YONG WP,YAP CS,et al.An integrative approach identified genes associated with drug response in gastric cancer[J].Carcinogenesis,2015,36(4):441-451.